GAP

The project GAP focuses on the area of "Patient safety and risk assessment" of the challenge 5 of FP7-ICT. It addresses, via specific workshops and studies, all aspects of risk prediction, evaluation of risk factors, evaluation and management tools designed for the preparation of means that allows an intervention in real situations. The project will evaluate insofar as possible all current solutions resulting from civil and military research on computerized decision-making on the topic of crisis management and, more specifically, major health crises.

The results of the project will add to the decision-making potential of the unit of information collection on health crises (Emergency Operations Facility of the Directorate General of Health and Consumer Protection) which brings together a range of computerized tools for the collection and transmission of information (H.E.O.F). The primary goal of this project is to bring together the emergent concepts which will permit us in the near future to predict, study, control and remedy the most complex of crises, those that jeopardise health. The challenge is to build a genuine system of health and social defence, and its components (concept, organisation, personnel, equipment, training..), at the European and world levels.

The project results should facilitate the creation of this system. At the same time, the partners are aware of the importance of the political decision and commitment. For this reason, GAP is driven from High-level representatives of HealthCare Ministries of EU countries and Associated States (Israel). The consortium and the experts associated with the Support Action GAP represent both of the complementary poles of excellence for the successful execution of this mission.

For further information, please visit:
http://www.gaptheproject.eu

Project co-ordinator:
Departament de Salut (Barcelona, Spain)

Partners:

  • Maccabi Healthcare Services
  • MedCom (Denmark)
  • KADRIS Consultants SARL (France)
  • Ecomit Consulting S.L. (Spain)
  • Ministry of Health (Israel)
  • Institut national de la santé et de la recherche médicale (France)
  • Region Syddanmark (Denmark)
  • Istituto Superiore di Sanità (Italy)
  • Ecole des Hautes Etudes en santé Publique (France)

Timetable: from 01/2008 - to 12/2008

Total cost: € 1.278.980

EC funding: € 930.707

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Coordination and support actions


Related news article:

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...